Coya Therapeutics COYA Growth Metrics (2022-2026)

NASDAQ COYA
$3.21 +0.05 (+1.58%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Coya Therapeutics Quarterly Growth Metrics

Periods 18 quarters
Latest Sep 2026

Coya Therapeutics reported revenue growth of -93.43% and asset growth of 48.96% for the quarter ended Sep 2026. These growth metrics cover 18 quarters of results from Jun 2022 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Growth Ratios
Share-based Compensation (QoQ)Stock Comp. (QoQ) 108.44%56.38%2.28%152.54%5.94%37.49%-9.42%83.05%52.03%17.01%2.01%36.62%-4.11%3.40%3.06%98.94%-57.01%-3.58%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y) 269.41%185.18%148.44%149.07%130.03%70.30%51.30%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 741.95%327.94%276.25%233.20%141.52%246.57%194.96%232.16%147.92%56.38%38.18%39.60%103.27%-8.86%-15.02%
Revenue (QoQ) -97.89%2,600.51%13,111.27%-36.55%2,078.43%11.10%-93.66%-2.95%-3.94%
Revenue Growth (1y) -99.97%103.32%-95.22%202,768.80%-2.61%48.97%-93.43%
Return on Sales [ROS] (QoQ)ROS (QoQ) -0.44M0.42M0.00M-20.89M20.61M-0.09M0.39M-0.01M-0.29M0.02M-0.18M
Return on Sales [ROS] Growth (1y)ROS Growth (1y) -20.91M0.13M-0.38M0.01M20.89M-0.01M0.10M-0.46M
Return on Equity [ROE] (QoQ)ROE (QoQ) 0.02M0.00M0.01M501.0091.00-280.000.00M-532.000.00M61.000.00M0.00M-105.000.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y) 0.02M0.00M0.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y) 0.03M0.00M0.01M0.00M0.00M0.00M0.00M0.00M543.000.00M-802.00
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 0.00M0.00M0.01M676.00-9.00-201.000.00M-475.000.00M113.00664.000.00M-264.000.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y) 0.00M0.00M0.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) 0.01M0.00M0.01M0.00M0.00M0.00M0.00M0.00M565.000.00M0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ) 0.00M0.00M0.01M417.0050.00-296.000.00M-403.000.00M120.00808.000.00M-216.000.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y) 0.00M0.00M0.00M
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 0.01M0.00M0.01M0.00M0.00M0.00M0.00M0.00M434.000.00M-981.00
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) -7.33%-7.91%-8.59%-9.40%-10.37%-11.57%-13.09%-15.06%-17.73%-21.54%-27.46%-37.86%-25.00%-33.33%-50.00%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) -31.62%-50.63%-53.99%-58.69%-66.22%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) -22.67%-29.32%-31.64%-34.36%-37.59%-41.49%-46.29%-52.35%-60.23%-70.91%-73.48%-77.46%-84.46%
Operating Margin (QoQ) -0.44M0.42M20.61M-0.09M0.39M-0.01M-0.29M0.02M-0.18M
Operating Margin Growth (1y) -20.91M0.13M-0.38M20.89M-0.01M0.10M-0.46M
Operating Income (QoQ)Op. Inc (QoQ) -102.67%22.76%24.73%-44.75%-12.22%-9.52%150.93%-402.07%40.98%-37.52%8.31%-88.15%16.44%62.07%-147.89%-26.68%7.76%-55.37%
Operating Income Growth (3y)Op. Inc Growth (3y) -65.28%-23.01%2.95%-44.39%-38.11%-29.37%-45.37%
Operating Income Growth (1y)Op. Inc Growth (1y) -70.56%5.57%-33.89%190.60%-89.06%0.56%-24.87%-324.79%-40.01%-98.22%45.33%-47.81%0.48%-9.86%-350.02%
Net Margin (QoQ) -0.40M0.39M14.65M-0.09M0.37M-0.01M-0.27M0.01M-453,489.65M
Net Margin Growth (1y) -14.94M0.11M-0.36M14.92M0.00M0.10M-453,489.92M
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -100.36%-17.81%22.71%11.94%-13.12%-10.55%137.00%-499.05%42.76%-39.07%27.49%-150.59%16.58%65.29%-169.80%-26.25%7.89%-159,947,551.94%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y) -62.48%-21.32%19.27%-22.47%-38.10%-28.96%-14,485.40%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -60.65%9.30%14.89%140.74%-84.61%6.58%-17.52%-330.32%-44.63%-110.78%47.39%-95.78%1.37%-8.91%-501,823,580.62%
Net Income (QoQ) -100.36%-17.81%22.71%11.94%-13.12%-10.55%137.00%-499.05%42.76%-39.07%27.49%-150.59%16.58%65.29%-169.80%-26.25%7.89%-59.95%
Net Income Growth (3y) -62.48%-21.32%19.27%-22.47%-38.10%-28.96%-45.85%
Net Income Growth (1y) -60.65%9.30%14.89%140.74%-84.61%6.58%-17.52%-330.32%-44.63%-110.78%47.39%-95.78%1.37%-8.91%-401.82%
Net Cash Flow (QoQ)NCF (QoQ) 494.99%-119.78%-69.68%482.26%-127.61%22.73%1,081.02%-84.53%-82.58%-1,042.10%231.98%-138.57%-105.52%80.75%1,781.83%-79.13%-293.33%2.18%
Net Cash Flow Growth (3y)NCF Growth (3y) -11.07%-39.47%11.46%107.08%-27.85%-38.04%-49.33%
Net Cash Flow Growth (1y)NCF Growth (1y) 606.68%-135.42%-38.39%900.12%-67.63%120.42%-148.98%-66.50%-183.54%-1,085.74%79.86%156.69%238.90%-30.66%-563.89%
Income After Tax (QoQ) -102.67%22.76%24.73%-44.75%-12.22%-9.52%150.93%-378.32%42.76%-53.90%8.31%-79.07%16.58%65.29%-169.66%-26.32%7.89%-59.95%
Income After Tax Growth (3y) -62.58%-20.93%7.37%-41.74%-35.45%-26.82%-43.89%
Income After Tax Growth (1y) -70.56%5.57%-33.89%190.60%-74.20%11.14%-24.87%-324.79%-44.63%-110.78%52.46%-39.83%1.37%-8.91%-401.82%
Free Cash Flow (QoQ)FCF (QoQ) 27.44%-10.52%-39.68%-73.80%25.77%22.73%-1.13%195.75%-312.67%-19.67%55.88%-17.37%-104.13%80.42%10.92%-516.46%-18.80%1.91%
Free Cash Flow Growth (3y)FCF Growth (3y) -12.53%-58.86%10.77%23.20%-17.13%-37.01%-48.35%
Free Cash Flow Growth (1y)FCF Growth (1y) -94.68%-99.15%-39.24%-0.81%155.54%-59.13%-146.44%-7.53%-231.80%-26.51%79.30%58.21%-119.52%-27.76%-539.94%
FCF Margin (QoQ) 0.17M-0.18M12.24M-0.24M0.35M629.00-0.24M-0.06M-0.01M
FCF Margin Growth (1y) -12.34M-0.28M-0.34M12.34M-0.14M0.05M-0.31M
EPS (Diluted) (QoQ) -100.35%-17.81%22.71%76.54%-10.55%-10.55%136.21%-380.53%44.52%-36.27%27.58%-128.39%16.61%65.30%-169.84%6.72%11.08%-159,947,551.94%
EPS (Diluted) Growth (3y) 12.74%34.85%56.65%34.24%-4.18%3.11%-10,858.14%
EPS (Diluted) Growth (1y) 57.20%76.38%77.84%110.38%-24.14%37.69%23.20%-253.61%-25.06%-87.97%52.14%-78.33%27.17%22.34%-357,966,262.40%
EPS (Basic) (QoQ) -100.35%-17.81%22.71%76.54%-10.55%-10.55%136.21%-380.53%44.52%-36.27%27.58%-128.39%16.61%65.30%-169.84%6.72%11.08%-159,947,551.94%
EPS (Basic) Growth (3y) 12.74%34.85%56.65%34.24%-4.18%3.11%-10,858.14%
EPS (Basic) Growth (1y) 57.20%76.38%77.84%110.38%-24.14%37.69%23.20%-253.61%-25.06%-87.97%52.14%-78.33%27.17%22.34%-357,966,262.40%
EBT (QoQ) -102.67%22.76%24.73%-44.75%-12.22%-9.52%150.93%-378.32%42.76%-53.90%8.31%-79.07%16.58%65.29%-169.66%-26.32%7.89%-59.95%
EBT Margin (QoQ) -0.40M0.39M20.62M-0.09M0.37M-0.01M-0.27M0.01M-0.18M
EBT Margin Growth (1y) -20.91M0.11M-0.36M20.89M0.00M0.10M-0.45M
EBT Growth (3y) -62.58%-20.93%7.37%-41.74%-35.45%-26.82%-43.89%
EBT Growth (1y) -70.56%5.57%-33.89%190.60%-74.20%11.14%-24.87%-324.79%-44.63%-110.78%52.46%-39.83%1.37%-8.91%-401.82%
EBIT (QoQ) -102.67%22.76%24.73%-44.75%-12.22%-9.52%150.93%-402.07%40.98%-37.52%8.31%-88.15%16.44%62.07%-147.89%-26.68%7.76%-55.37%
EBIT Margin (QoQ) -0.44M0.42M20.61M-0.09M0.39M-0.01M-0.29M0.02M-0.18M
EBIT Margin Growth (1y) -20.91M0.13M-0.38M20.89M-0.01M0.10M-0.46M
EBIT Growth (3y) -65.28%-23.01%2.95%-44.39%-38.11%-29.37%-45.37%
EBIT Growth (1y) -70.56%5.57%-33.89%190.60%-89.06%0.56%-24.87%-324.79%-40.01%-98.22%45.33%-47.81%0.48%-9.86%-350.02%
EBITDA Margin (QoQ) -0.43M0.42M20.57M-0.09M0.38M-0.01M-0.29M0.02M-0.18M
EBITDA Margin Growth (1y) -20.87M0.13M-0.38M20.85M-0.01M0.10M-0.46M
Cash from Operations (QoQ)Cash from Ops. (QoQ) 27.44%-10.52%-39.68%-73.80%25.77%22.73%-1.13%195.75%-312.67%-19.67%55.88%-17.37%-104.13%80.42%10.92%-516.46%-18.80%1.91%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y) -12.53%-58.86%10.77%23.20%-17.13%-37.01%-48.35%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -94.68%-99.15%-39.24%-0.81%155.54%-59.13%-146.44%-7.53%-231.80%-26.51%79.30%58.21%-119.52%-27.76%-539.94%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) 87.06%-36.45%99.81%-1,303.38%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y) -18.48%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) 50.47%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) 175.04%-19.72%-16.91%199.71%10.34%1.67%-15.03%23.28%-7.33%-16.13%-5.60%66.45%8.33%-14.83%-17.12%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) 106.72%99.09%45.94%48.84%48.71%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 36.72%449.86%120.58%179.34%185.68%17.51%-1.30%-18.58%-9.55%22.13%42.76%44.97%27.27%
Assets (QoQ) 107.48%-16.93%-17.79%246.88%-9.38%6.81%-10.98%24.74%-13.40%-12.90%-4.21%55.89%6.65%-11.19%-16.89%
Assets Growth (3y) 109.95%81.20%45.15%48.42%48.96%
Assets Growth (1y) 75.20%391.48%114.67%176.02%198.87%7.48%2.71%-16.24%-9.87%12.63%38.71%41.42%22.70%

Coya Therapeutics Growth Metrics API

Pull Coya Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=COYA&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY